Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis
Clinical trial NCT04307862 · UNKNOWN
Trial details
- NCT number
- NCT04307862
- Sponsor
- Shulov Innovate for Science Ltd. 2012
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-29
- Primary completion
- 2024-12-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.